173 related articles for article (PubMed ID: 17593169)
1. Sequential combination therapy for chronic hepatitis B: more challenges to be tackled.
Tseng TC; Liu CJ; Kao JH
Am J Gastroenterol; 2007 Jul; 102(7):1544; author reply 1545. PubMed ID: 17593169
[No Abstract] [Full Text] [Related]
2. [Focusing on the markers for monitoring and antiviral therapy in chronic hepatitis B virus infection].
Wei L
Zhonghua Gan Zang Bing Za Zhi; 2006 Nov; 14(11):836-7. PubMed ID: 17125613
[No Abstract] [Full Text] [Related]
3. [Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
Marcellin P; Lada O
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S5-8. PubMed ID: 17075487
[No Abstract] [Full Text] [Related]
4. Chronic hepatitis B: back to the future with HBsAg.
Moucari R; Lada O; Marcellin P
Expert Rev Anti Infect Ther; 2009 Aug; 7(6):633-6. PubMed ID: 19681689
[No Abstract] [Full Text] [Related]
5. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
Bourlière M
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
[No Abstract] [Full Text] [Related]
6. Treatment of children persistently infected with hepatitis B virus: seroconversion or suppression.
Price N; Boxall EH
J Antimicrob Chemother; 2007 Dec; 60(6):1189-92. PubMed ID: 17913721
[TBL] [Abstract][Full Text] [Related]
7. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
Locarnini S; Warner N
Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179
[TBL] [Abstract][Full Text] [Related]
8. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
Hofmann WP; Soriano V; Zeuzem S
Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
[TBL] [Abstract][Full Text] [Related]
9. [Managing resistance to analogue antiviral drugs in a chronic compensated hepatitis B patient].
Bronowicki JP; Barraud H; Couzigou P
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S17-9. PubMed ID: 17075490
[No Abstract] [Full Text] [Related]
10. Changing landscape of antiviral resistance management in chronic hepatitis B.
Nguyen T; Locarnini S; Desmond P
J Gastroenterol Hepatol; 2008 Sep; 23(9):1314-7. PubMed ID: 18853991
[No Abstract] [Full Text] [Related]
11. Chronic hepatitis B infection in pregnancy illustrated by a case of successful treatment with entecavir.
Kakogawa J; Sakurabashi A; Sadatsuki M; Gomibuchi H; Minoura S
Arch Gynecol Obstet; 2011 Dec; 284(6):1595-6. PubMed ID: 21861151
[No Abstract] [Full Text] [Related]
12. [Treatment of sever polyneuropathy caused by hepatitis B virus with interferon alpha].
Il'iankova AA; Krel' PE; Komiagin IuV; Il'ina NA
Ter Arkh; 1998; 70(11):24-5. PubMed ID: 9949451
[No Abstract] [Full Text] [Related]
13. Chronic hepatitis B: preventing, detecting, and managing viral resistance.
Keeffe EB; Dieterich DT; Pawlotsky JM; Benhamou Y
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):268-74. PubMed ID: 18328434
[TBL] [Abstract][Full Text] [Related]
14. Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response?
Wiegand J; Patel K; Tillmann HL
Hepatology; 2009 Oct; 50(4):1314; author reply 1314. PubMed ID: 19676132
[No Abstract] [Full Text] [Related]
15. Revisiting the treatment recommendations for chronic hepatitis B.
Chan HL
Hepatology; 2009 Feb; 49(2):700; author reply 701-2. PubMed ID: 19177582
[No Abstract] [Full Text] [Related]
16. Antiviral therapy of chronic hepatitis B: prevention of drug resistance.
Fournier C; Zoulim F
Clin Liver Dis; 2007 Nov; 11(4):869-92, ix. PubMed ID: 17981233
[TBL] [Abstract][Full Text] [Related]
17. Can serum HBV-DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B?
Alberti A
Hepatology; 2003 Jul; 38(1):18-20. PubMed ID: 12829981
[No Abstract] [Full Text] [Related]
18. New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA.
Zoulim F
J Hepatol; 2005 Mar; 42(3):302-8. PubMed ID: 15710212
[No Abstract] [Full Text] [Related]
19. Hepatitis B virus carriers; natural course, diagnostic approach and treatment.
Ranjan P; Aggarwal R
Trop Gastroenterol; 2005; 26(2):58-65. PubMed ID: 16225046
[No Abstract] [Full Text] [Related]
20. Treatment of chronic hepatitis B and the implications of viral resistance to therapy.
Mauss S; Wedemeyer H
Expert Rev Anti Infect Ther; 2008 Apr; 6(2):191-9. PubMed ID: 18380601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]